Evidence map›Paper›PMID 31497487›Full record

ArticleJIMD reports2019

Clinical findings in Brazilian patients with adult GM1 gangliosidosis.

Luciana Giugliani, Carlos Eduardo Steiner, Chong Ae Kim, Charles Marques Lourenço, Mara Lucia Schmitz Ferreira Santos, Carolina Fischinger Moura de Souza, Ana Carolina Brusius-Facchin, Guilherme Baldo, Mariluce Riegel, Roberto Giugliani

Open access · goldAbstract read
In one paragraph

Article in JIMD reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. GM1 gangliosidosis type II: Results of a 10-year prospective study.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Observational
  2. Article
  3. GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study.medRxiv : the preprint server for health sciences · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Luciana GiuglianiNational Institute of Population Medical Genetics (INAGEMP) Porto Alegre Brazil.
Carlos Eduardo SteinerDepartment of Medical Genetics Faculdade de Medicina, UNICAMP Campinas Brazil.
Chong Ae KimInstituto da Criança Hospital das Clínicas, FM, USP São Paulo Brazil.
Charles Marques LourençoCentro Universitário Estácio de Ribeirão Preto Ribeirão Preto Brazil.
Mara Lucia Schmitz Ferreira SantosHospital Infantil Pequeno Príncipe Curitiba Brazil.
Carolina Fischinger Moura de SouzaMedical Genetics Service, HCPA Porto Alegre Brazil.
Ana Carolina Brusius-FacchinMedical Genetics Service, HCPA Porto Alegre Brazil.
Guilherme BaldoGene Therapy Center, HCPA Porto Alegre Brazil.
Mariluce RiegelMedical Genetics Service, HCPA Porto Alegre Brazil.
Roberto GiuglianiNational Institute of Population Medical Genetics (INAGEMP) Porto Alegre Brazil.ORCID https://orcid.org/0000-0001-9655-3686
National Institute on Population Medical Genetics · BRUniversidade Federal do Rio Grande do Sul · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital Erasto Gaertner · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GM1 gangliosidosis is a lysosomal storage disorder caused by β-galactosidase deficiency. To date, prospective studies for GM1 gangliosidosis are not available, and only a few have focused on the adult form. This retrospective cross-sectional study focused on clinical findings in Brazilian patients with the adult form of GM1 gangliosidosis collected over 2 years. Ten subjects were included in the study. Eight were males and two females, with median age at diagnosis of 11.5 years (IQR, 4-34 years). Short stature and weight below normal were seen in five out of the six patients with data available. Radiological findings revealed that the most frequent skeletal abnormalities were beaked vertebrae, followed by hip dysplasia, and platyspondyly. Neurological examination revealed that dystonia and swallowing problems were the most frequently reported. None of the patients presented hyperkinesia, truncal hypertonia, Parkinsonism, or spinal cord compression. Clinical evaluation revealed impairment in activities of cognitive/intellectual development and behavioral/psychiatric disorders in all nine subjects with data available. Language/speech impairment (dysarthria) was found in 8/9 patients, fine motor and gross motor impairments were reported in 7/9 and 5/9 patients, respectively. Impairment of cognition and daily life activities were seen in 7/9 individuals. Our findings failed to clearly identify typical early or late alterations presented in GM1 gangliosidosis patients, which confirms that it is a very heterogeneous condition with wide phenotypic variability. This should be taken into account in the evaluation of future therapies for this challenging condition.

Indexed as

beta‐galactosidase deficiencyBrazilGM1 gangliosidosisINAGEMPlate onsetsphingolipidosis

Identifiers

PMID31497487
PMCPMC6718113
OpenAlexW2961586695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.